nach oben

Abdominal Radiology

Erschienen in:

02.05.2023 | Hollow Organ GI

Comparison of the magnetic resonance scoring systems for Crohn’s disease activity: MaRIA, simplified MaRIA, and Nancy scores

verfasst von: Wei-En Lee, Meng-Tzu Weng, Shu-Chen Wei, I-Lun Shih

Erschienen in: Abdominal Radiology | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The most widely used score for assessing the activity of Crohn’s disease (CD) is the Magnetic Resonance Index of Activity (MaRIA) score, but it is time-consuming. The aim of this study was to compare the diagnostic accuracy of MaRIA score to the other two easily calculated scores.

Methods

Between January 2011 and May 2021, 67 patients with CD who underwent MRE and ileocolonoscopy within 2 weeks were enrolled. The MRE-based scores including the MaRIA score, simplified MaRIA (sMaRIA) score, and Nancy score for each colonic segment and terminal ileum were calculated and correlated with the ileocolonoscopic findings. The simplified endoscopic score for Crohn's disease (SES-CD) was considered the gold standard.

Results

A total of 343 intestinal segments were included in the analysis, of which 109 (31.8%) showed active inflammation on ileocolonoscopy. The areas under the receiver operating characteristic curve (AUC) of the MaRIA, sMaRIA, and Nancy scores for detecting active disease were 0.752, 0.764, and 0.765, respectively. In the sub-analysis for different indications, the MaRIA and sMaRIA scores showed a higher AUC (0.721 and 0.741) than the Nancy score (0.652) for disease monitoring.

Conclusion

The sMARIA and Nancy scores showed comparable diagnostic accuracy to the MaRIA score, and thus could be used as alternatives to the MaRIA score. Furthermore, considering the range of application, especially for disease monitoring, the sMaRIA score may be more suitable for use in clinical practice.

Graphical abstract

Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019;13:144-164. https://doi.org/10.1093/ecco-jcc/jjy113CrossRefPubMed

Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: Management of Crohn's disease in adults. Am J Gastroenterol 2018;113:481-517. https://doi.org/10.1038/ajg.2018.27CrossRefPubMed

Coimbra AJ, Rimola J, O'Byrne S, Lu TT, Bengtsson T, de Crespigny A, et al. Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation. Aliment Pharmacol Ther 2016;43:61-72. https://doi.org/10.1111/apt.13453CrossRefPubMed

Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 2: IBD scores and general principles and technical aspects. J Crohns Colitis 2019;13:273-284. https://doi.org/10.1093/ecco-jcc/jjy114CrossRefPubMed

D'Amico F, Chateau T, Laurent V, Danese S, Peyrin-Biroulet L. Which MRI score and technique should be used for assessing Crohn's disease activity?. Journal of clinical medicine 2020; 9(6), 1691. https://doi.org/10.3390/jcm9061691CrossRefPubMedPubMedCentral

Rozendorn N, Amitai MM, Eliakim RA, Kopylov U, Klang E. A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation. Therap Adv Gastroenterol 2018;11:1756284818765956. https://doi.org/10.1177/1756284818765956CrossRefPubMedPubMedCentral

Scardapane A, Ambrosi A, Salinaro E, Mancini ME, Principi M, Di Leo A, et al. Assessment of disease activity in small bowel Crohn's disease: Comparison between endoscopy and magnetic resonance enterography using MRIA and modified MRIA score. Gastroenterol Res Pract 2015;2015:159641. https://doi.org/10.1155/2015/159641

Sato H, Tamura C, Narimatsu K, Shimizu M, Takajyo T, Yamashita M, et al. Magnetic resonance enterocolonography in detecting erosion and redness in intestinal mucosa of patients with Crohn's disease. J Gastroenterol Hepatol 2015;30:667-673. https://doi.org/10.1111/jgh.12851CrossRefPubMed

Tielbeek JA, Makanyanga JC, Bipat S, Pendse DA, Nio CY, Vos FM, et al. Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity. AJR Am J Roentgenol 2013;201:1220-1228. https://doi.org/10.2214/AJR.12.10341CrossRefPubMed

10.

Ye L, Cheng W, Chen BQ, Lan X, Wang SD, Wu XC, et al. Levels of faecal calprotectin and magnetic resonance enterocolonography correlate with severity of small bowel Crohn's disease: A retrospective cohort study. Sci Rep 2017;7:1970. https://doi.org/10.1038/s41598-017-02111-6CrossRefPubMedPubMedCentral

11.

Ordas I, Rimola J, Alfaro I, Rodriguez S, Castro-Poceiro J, Ramirez-Morros A, et al. Development and validation of a simplified magnetic resonance index of activity for Crohn's disease. Gastroenterology 2019;157:432–439 e431. https://doi.org/10.1053/j.gastro.2019.03.051

12.

Oussalah A, Laurent V, Bruot O, Bressenot A, Bigard MA, Regent D, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010;59:1056-1065. https://doi.org/10.1136/gut.2009.197665CrossRefPubMed

13.

Steward MJ, Punwani S, Proctor I, Adjei-Gyamfi Y, Chatterjee F, Bloom S, et al. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 2012;81:2080-2088. https://doi.org/10.1016/j.ejrad.2011.07.013CrossRefPubMed

14.

Buisson A, Joubert A, Montoriol PF, Da Ines D, Hordonneau C, Pereira B, et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease. Aliment Pharmacol Ther 2013;37:537-545. https://doi.org/10.1111/apt.12201CrossRefPubMed

15.

Rimola J, Alvarez-Cofino A, Perez-Jeldres T, Ayuso C, Alfaro I, Rodriguez S, et al. Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease. J Gastroenterol 2017;52:585-593. https://doi.org/10.1007/s00535-016-1253-6CrossRefPubMed

16.

Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505-512. https://doi.org/10.1016/s0016-5107(04)01878-4CrossRefPubMed

17.

Rimola J, Rodriguez S, Garcia-Bosch O, Ordas I, Ayala E, Aceituno M, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009;58:1113-1120. https://doi.org/10.1136/gut.2008.167957CrossRefPubMed

18.

Capozzi N, Ordas I, Fernandez-Clotet A, Castro-Poceiro J, Rodriguez S, Alfaro I, et al. Validation of the simplified magnetic resonance index of activity [sMARIA] without gadolinium-enhanced sequences for Crohn's disease. J Crohns Colitis 2020;14:1074-1081. https://doi.org/10.1093/ecco-jcc/jjaa030CrossRefPubMed

19.

Roseira J, Ventosa AR, de Sousa HT, Brito J. The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels a simple endoscopic index and fecal calprotectin. United European Gastroenterol J 2020;8:1208-1216. https://doi.org/10.1177/2050640620943089CrossRefPubMedPubMedCentral

20.

Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011;34:125–145. https://doi.org/10.1111/j.1365-2036.2011.04710.x

Titel: Comparison of the magnetic resonance scoring systems for Crohn’s disease activity: MaRIA, simplified MaRIA, and Nancy scores
verfasst von: Wei-En Lee
Meng-Tzu Weng
Shu-Chen Wei
I-Lun Shih
Publikationsdatum: 02.05.2023
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 7/2023
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-023-03926-w

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Comparison of the magnetic resonance scoring systems for Crohn’s disease activity: MaRIA, simplified MaRIA, and Nancy scores

Abstract

Purpose

Methods

Results

Conclusion

Graphical abstract

Neu im Fachgebiet Radiologie

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

Update Radiologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2023

Diagnostic performance of multiparametric magnetic resonance imaging in the differentiation of clear cell renal cell cancer

MRI-based nomograms and radiomics in presurgical prediction of extraprostatic extension in prostate cancer: a systematic review

PI-RADS 3 lesions: a critical review and discussion of how to improve management

Early vs. late percutaneous catheter drainage of acute necrotic collections in patients with necrotizing pancreatitis

Intra-examination agreement between multi-echo gradient echo and confounder-corrected chemical shift-encoded MR sequences for R2* estimation as a biomarker of liver iron content in patients with a wide range of T2*/R2* and proton density fat fraction values

US-guided trocar versus Seldinger technique for percutaneous cholecystostomy (TROSELC II trial)

Neu im Fachgebiet Radiologie

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

Update Radiologie

Intra-examination agreement between multi-echo gradient echo and confounder-corrected chemical shift-encoded MR sequences for R2* estimation as a biomarker of liver iron content in patients with a wide range of T2/R2 and proton density fat fraction values